|
Biogen Idec, Inc. v. GlaxoSmithKline LLC (Fed. Cir. 2013)
Patent Docs The examiner acknowledged that the specification was enabling for Biogen’s chimeric gamma 1 anti-human CD20 antibody, Rituxan® (rituximab), but was silent concerning the specificity and affinity that would be necessary for other anti-CD20 antibodies. |
|
Scientists find ethnicity linked to antibodies – Medical Xpress
Medical Xpress Scientists find ethnicity linked to antibodies. April 17, 2013 in Genetics. Scientists find ethnicity linked to antibodies. Enlarge. Corey Watson. (Medical Xpress)—Cracking the DNA code for a complex region of the human genome has helped 14 North … |
Insider Monkey (blog)Biogen Idec Inc. (BIIB): What Goes up Must Come DownInsider Monkey (blog)On April 4, the company announced positive results from the phase 2 study of daclizumab HYP, another drug for MS which Biogen is developing in partnership wit…
 University of Delaware |
Human antibodies topic of Robert Pigford Memorial Lecture
University of Delaware 11:23 a.m., April 16, 2013–George Georgiou of the University of Texas Austin will speak on the topic “What’s In Your Blood: Systems Analysis of Human Antibody Immunity” when he presents the Robert Pigford Memorial Lecture at 10 a.m., Wednesday, May 1, … |
R-CVP yielded lowest time-to-treatment failure rate in follicular lymphomaHealioResearchers who evaluated three rituximab-containing regimens among patients with follicular lymphoma reported rituximab plus cyclophosphamide, vincristine and prednisone w…
|
Promising results in treating a lymphoma in young people – Science Daily
Science Daily (press release) Wyndham Wilson, M.D., Ph.D., head of NCI’s Lymphoma Therapeutics Section, and colleagues conducted the trial, in which every patient received the drugs etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, and rituximab in a regimen … |
 Manchester Evening News |
Fresh hope for eye disease sufferers who cannot cry
Manchester Evening News Arthritis Research UK has given a grant of £945,412 for the trial in a bid to find a more effective way to tackle the condition. The researchers are aiming to find out if an existing treatment for rheumatoid arthritis, the drug Rituximab, can also be … |
 Leukaemia & Lymphoma Research |
£1 million for Southampton lymphoma drug research
Leukaemia & Lymphoma Research The introduction of a monoclonal antibody called rituximab over a decade ago heralded their use as an effective treatment for cancer. It doubled the long-term survival rates for many different types of lymphoma when used in combination with chemotherapy. |
Pharmacyclics Earns 4th Milestone – Analyst BlogNASDAQThe third milestone payment of $50 million was triggered on Oct 15, 2012, when Pharmacyclics announced the enrollment of the fifth patient in an international, randomized phase III clinical trial of…
Traders Recap: Biogen Idec, Array Biopharma, Universal Display, AmgenSBWire (press release)The company, on April 4, announced that results from the daclizumab high-yield process (DAC HYP) SELECT clinical trial have been published as an online article i…